1. Home
  2. UEC vs GKOS Comparison

UEC vs GKOS Comparison

Compare UEC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uranium Energy Corp.

UEC

Uranium Energy Corp.

HOLD

Current Price

$13.91

Market Cap

9.0B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$102.80

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEC
GKOS
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
5.6B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
UEC
GKOS
Price
$13.91
$102.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
14
Target Price
$17.83
$133.07
AVG Volume (30 Days)
7.6M
652.0K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,837,000.00
$507,442,000.00
Revenue This Year
N/A
$23.39
Revenue Next Year
$144.72
$27.46
P/E Ratio
N/A
N/A
Revenue Growth
29737.95
32.33
52 Week Low
$3.85
$73.16
52 Week High
$20.34
$130.23

Technical Indicators

Market Signals
Indicator
UEC
GKOS
Relative Strength Index (RSI) 43.86 39.88
Support Level $11.86 $81.54
Resistance Level $14.64 $103.63
Average True Range (ATR) 1.00 3.77
MACD -0.08 -1.65
Stochastic Oscillator 45.38 25.39

Price Performance

Historical Comparison
UEC
GKOS

About UEC Uranium Energy Corp.

Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: